A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Clinical trial NCT00967811 · COMPLETED

Trial details

NCT number: NCT00967811
Sponsor: Mati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2009-08-01
Primary completion: 2010-05-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.